Libman-Sacks Endocarditis and Oral Anticoagulation;Endocardite de Libmann-Sacks e Anticoagulação Oral

Arquivos Brasileiros de Cardiologia

Volumn 82, Issue 4, 2004, Pages 378-383

  Brito, Fabiano Almeida ^a,b,c   Tófani, Magali LMC ^a,b,c   Ávila Tófani, Fábio ^a,b,c   Kakehasi, Adriana Maria ^a,b,c   Duarte Lanna, Cristina Costa ^a,b,c   Parreiras Carvalho, Marco Antonio ^a,b,c  

^a UFMG ^*

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; WARFARIN;

ADULT; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; CONVULSION; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; ENDOCARDITIS; FEMALE; HEART AUSCULTATION; HEART MURMUR; HUMAN; LIBMAN SACKS ENDOCARDITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MITRAL VALVE; WARFARIN;

EID: 2442453633     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Libman E, Sacks B. A hitherto undescribed form of valvular and mural endocarditis. Arch Intern Med 1924; 33: 701-37.
2. Galvi E, Candell-Rivera J, Pigaro C, Permanyer-Miralda G, Garcia-Del-Castillo H, Soler-Soler J. Prevalence morphologic types end evolution of cardiac valvular disease in systemic lupus erythematosus. N Engl J Med 1988; 1988: 817-23.
3. Bulkcley BH, Roberts WC. The heart in systemic lupus erythematosus and the changes induced in it by corticosterold therapy. Am J Med, 1975; 58: 243-64.
4. Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 1987; 17: 126-41.
5. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvment (Libman-Sacks endocarditis) in the antiphospholipid antibody syndrome. Circulation 1996; 93: 1579-87.
6. Gabrielli F, Alcini E, Di Prima MA et al. Cardiac valve involvement em SLE and primary antiphospholipid antibody syndrome: lack of correlation with antiphospholipid antibodies. Int J Cardiol, 1995; 51: 117-26.
7. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus eruthematosus. Arthritis Rheum, 1997; 40: 1725.
8. Roldan CA. Valvular disease associated with systemic illness. Cardiol Clin 1998; 16: 531-50.
9. Roldan CA, Shively BK, Crawford MH. An echocardiografic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med 1996; 335: 1424-30.
10. Longo JL, Remetz MS. Cardiovascular manifestations of systemic autoimmune diseases. Clin Chest Med 1998; 19: 793-808.
11. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-63.
12. Khamashta MA, Cuadrado MJ, Mujic F, Taub NA, Hunt BJ, Hughes GRV. The management of thrombosis in the antiphospholipid antibody syndrome. N Engl J Med 1995; 332: 993-7.
13. Lockshin MD. Answers to the antiphospholipid antibody syndrome? N Engl J Med 1995; 332: 1025-27.
14. Petri M. Pathogenesis and treatment of the antiphospholipid antibody syndrome. Med Clin North Am 1997; 81: 151-77.
15. Petri M. Management of thrombosis in antiphospholipid antibody syndrome. Rheum Dis Clin North Am 2001; 27: 633-42.
16. Levy RA, Vilela VS, Síndrome do Anticorpo Antifosfolípide. In: Moreira C, Carvalho MAP. Reumatologia-Diagnóstico e Tratamento. 2ed. MEDSI, 2001; 511-22.
17. O'Neill D, Magaldi J, Dobkins D, Greco T. Dissolution of intracardiac mass lesions in the primary antiphospholipid syndrome. Arch Intern Med 1995; 155: 325-7.
18. Skyrme-Jones ARP, Wardrof CAJ, Wiles CM, Fraser AG. Transesophageal echocardiographic demonstration of resolution of mitral vegetations after warfarin in a patient with primary antiphospholipid syndrome. J Am Soc Echocardiogr 1995; 8: 251-6.
19. Agirbasli MA, Hansen DE, Byrd III BF. Resolution of vegetations with anticoagulation after myocardial infarction in primary antiphospholipid syndrome. J Am Soc Echocardiogr 1997; 10: 877-80.
20. Espinola-Zavaleta N, Vargas-Barron J, Colmenares-Galvis T, et al. Echocardiographic evaluation of patients with primary antiphospholipid syndrome. Am Heart J 1999; 137: 973-9.
21. Amaral G, Santos Junior EH, de Azevedo LC, de Azevedo LA, Pimenta J. Nonbacterial thrombotic endocarditis. Arq Bras Cardiol 1997; 68(5): 373-5.
22. Cocito L, Favale E, Reni L. Epileptic seizures in cerebral arterial occlusive disease. Stroke 1982; 13: 189-95.
23. Herranz MT, Rivier G, Khamashta MA. Association between antiphospholipid antibodies and epilepsy in patients with systemic lupus erythematosus. Arthritis Rheum 1994; 37: 568-71.